Center for Mental Health Services and Policy Research
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT00264823
The purpose of this research study is to investigate how nurses can best help people with serious mental illnesses (SMI) follow their HIV treatment plans.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Philadelphia, Pennsylvania, 19104, United States
There is concern that HIV positive SMI persons may be a greater risk for poor treatment adherence, increasing risk for poorer outcomes and development of treatment resistance virus, and also placing others at greater risk. Involvement of advance practice nurses has been previously shown to improve outcomes for persons with HIV/AIDS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Experimental participants will receive an integrated intervention tailored to the communication and comprehension of the individual, and will include memory aid devices, education regarding side effects and other treatment aspects, and active community outreach. For those who fail to adhere using the basic intervention, a treatment cascade that increases in intensity will be implemented. Using 80% adherence as a target, the cascade will include involvement of family and significant others in prompting participants through use of beepers, cellphones, and for those who still fall short of 80% adherence, directly observed therapy.
Time frame: baseline, 3, 12 and 24 months
National Institute of Nursing Research (NINR)
Nih
Nursing Intervention for HIV Regimen Adherence Among Serious Mental Illness (SMI)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT05125458
Acquired Immunodeficiency Syndrome, Atopic Dermatitis
Naples, Italy
View Trial DetailsNCT03348813
Affective Symptoms, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05700474
Behavior, Chemically-Induced Disorders
Charlotte, North Carolina, United States
View Trial Details